NovAccess Global Inc. (OTCMKTS:XSNX) Sees Significant Decrease in Short Interest

NovAccess Global Inc. (OTCMKTS:XSNXGet Free Report) was the recipient of a large drop in short interest in August. As of August 15th, there was short interest totalling 400 shares, a drop of 71.4% from the July 31st total of 1,400 shares. Based on an average trading volume of 2,200 shares, the short-interest ratio is currently 0.2 days.

NovAccess Global Stock Performance

Shares of XSNX opened at $0.11 on Friday. The stock has a 50-day moving average of $0.11 and a 200-day moving average of $0.15. NovAccess Global has a one year low of $0.06 and a one year high of $0.42.

NovAccess Global Company Profile

(Get Free Report)

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

Featured Stories

Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with's FREE daily email newsletter.